Nursing Homes that have struggled to reduce the use of antipsychotic medications will now be subject to enhanced oversight and enforcement. Identified as “non-improving late adopters,” providers with two or more deficiency citations in the areas of Chemical Restraints (F605), Dementia Care (F744) or Psychotropic Medications (F758) may be subject to fines and penalties to include discretionary Denials of Payment for New Admissions and Civil Monetary Penalties.
Read LeadingAge National article for a detailed summary.
